Mural Oncology Statistics
Total Valuation
Mural Oncology has a market cap or net worth of $57.22 million. The enterprise value is -$108.74 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, before market open.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Mural Oncology has 17.08 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Current Share Class | 17.08M |
| Shares Outstanding | 17.08M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 1.87% |
| Owned by Institutions (%) | 43.31% |
| Float | 13.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.05.
| Current Ratio | 7.38 |
| Quick Ratio | 7.13 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -183.89% and return on invested capital (ROIC) is -103.04%.
| Return on Equity (ROE) | -183.89% |
| Return on Assets (ROA) | -85.30% |
| Return on Capital (ROIC) | -103.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 117 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Mural Oncology has paid $1.98 million in taxes.
| Income Tax | 1.98M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -4.56% |
| 50-Day Moving Average | 3.41 |
| 200-Day Moving Average | 3.71 |
| Relative Strength Index (RSI) | 43.09 |
| Average Volume (20 Days) | 56,438 |
Short Selling Information
The latest short interest is 412,862, so 2.42% of the outstanding shares have been sold short.
| Short Interest | 412,862 |
| Short Previous Month | 392,793 |
| Short % of Shares Out | 2.42% |
| Short % of Float | 2.99% |
| Short Ratio (days to cover) | 3.85 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -159.32M |
| Pretax Income | n/a |
| Net Income | -153.78M |
| EBITDA | -156.06M |
| EBIT | -159.32M |
| Earnings Per Share (EPS) | -$9.12 |
Full Income StatementBalance Sheet
The company has $175.50 million in cash and $9.55 million in debt, giving a net cash position of $165.96 million or $9.72 per share.
| Cash & Cash Equivalents | 175.50M |
| Total Debt | 9.55M |
| Net Cash | 165.96M |
| Net Cash Per Share | $9.72 |
| Equity (Book Value) | 174.14M |
| Book Value Per Share | 10.22 |
| Working Capital | 158.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$139.50 million and capital expenditures -$1.25 million, giving a free cash flow of -$140.75 million.
| Operating Cash Flow | -139.50M |
| Capital Expenditures | -1.25M |
| Free Cash Flow | -140.75M |
| FCF Per Share | -$8.24 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |